Ex Parte SIMS et al - Page 8


                 Appeal No.  1999-1430                                                                                
                 Application No.  08/441,893                                                                          
                               of inoperative combinations becomes significant, and in                                
                               effect forces one of ordinary skill in the art to experiment                           
                               unduly in order to practice the claimed invention, the claims                          
                               might indeed be invalid.  See, e.g., In re Cook, 439 F.2d                              
                               730, 735, 169 USPQ 298, 302 (CCPA 1971).                                               
                 However, on this record, the examiner has not provided the evidence necessary                        
                 to demonstrate that one of ordinary skill in the art would be forced to experiment                   
                 unduly n order to practice the claimed invention.                                                    
                        Furthermore, it appears that events may have overtaken this ground of                         
                 rejection.  In this regard, we direct the examiner’s attention to United States                      
                 Patent No. 5,350,683 (‘683) issued September 27, 1994.  The instant application                      
                 is a continuation of the Sims patent, which is a divisional of the ‘683 patent.                      
                        We direct the examiner’s attention to claim 1 of the ‘683 patent:                             
                           1. An isolated DNA selected from the group consisting of:                                  
                               (a) a cDNA clone having a nucleotide sequence encoding an amino                        
                                  acid sequence of amino acids 1 through 385 of SEQ ID NO.:2;                         
                               (b) a DNA capable of hybridization to a clone of (a) under                             
                                  moderately stringent conditions and which encodes a                                 
                                  biologically active type II IL-1R molecule; and                                     
                               (c) a DNA having a sequence which is degenerate as a result of                         
                                  the genetic code to a DNA as defined in (a) or (b) above and                        
                                  which encodes biologically active type II IL-1R molecules.                          
                        Part “(b)” of this claim is drawn to a DNA that encodes a biologically active                 
                 type II IL-1R molecule and is capable of hybridization under moderately stringent                    
                 conditions to a cDNA clone having a nucleotide sequence encoding an amino                            
                 acid sequence of amino acids 1 through 385 of SEQ ID NO.:2.  We note the                             
                 similarity of this DNA claim to appealed claim 16 drawn, in part, to an isolated                     
                 and purified Type II IL-1 receptor that binds IL-1 and is encoded by a DNA that                      
                 hybridizes under moderately stringent conditions with a DNA selected from the                        


                                                          8                                                           



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007